Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

A research team from Columbia Engineering and the Irving Institute for Cancer Dynamics made a pivotal discovery in the field ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

Researchers identified a unique population of immune cells that significantly enhance treatment outcomes for relapsed acute myeloid leukemia (AML). Conducted in collaboration with the Dana Farber ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...